As of April 16, 2025, MannKind Corp (MNKD) has a market cap of $1.41 billion USD. According to our data, MannKind Corp is ranked No.4527 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $1.41 B |
-20.49%
|
Dec 31, 2024 | $1.77 B |
76.65%
|
Dec 29, 2023 | $1.00 B |
-30.93%
|
Dec 30, 2022 | $1.45 B |
20.59%
|
Dec 31, 2021 | $1.21 B |
39.62%
|
Dec 31, 2020 | $0.86 B |
142.64%
|
Dec 31, 2019 | $0.36 B |
21.70%
|
Dec 31, 2018 | $0.29 B |
-54.31%
|
Dec 29, 2017 | $0.64 B |
-27.50%
|
Dec 30, 2016 | $0.88 B |
-55.86%
|
Dec 31, 2015 | $2.00 B |
-72.22%
|
Dec 31, 2014 | $7.20 B |
0.38%
|
Dec 31, 2013 | $7.17 B |
125.11%
|
Dec 31, 2012 | $3.19 B |
-7.60%
|
Dec 30, 2011 | $3.45 B |
-68.98%
|
Dec 31, 2010 | $11.11 B |
-7.99%
|
Dec 31, 2009 | $12.08 B |
155.39%
|
Dec 31, 2008 | $4.73 B |
-56.91%
|
Dec 31, 2007 | $10.98 B |
-51.73%
|
Dec 29, 2006 | $22.74 B |
46.45%
|
Dec 30, 2005 | $15.53 B |
-28.51%
|
Dec 31, 2004 | $21.72 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Novo Nordisk
NVO
|
$286.98 B |
70.023 B
|
![]() Denmark
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
![]() Israel
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
Market Cap | = | MNKD Stock Price | * | MNKD Shares Outstanding |
= | $4.64 | * | 0.30 B | |
= | $1.41 B |